Repurposing rheumatology drugs for COVID-19: TNF inhibitors (with Philip Robinson)

Share:

Medicine Matters rheumatology

Miscellaneous

Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.